Navigation Links
Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
Date:9/25/2008

Company also announces FDA approval of TAXUS(R) Express2(TM) Stent System

for treatment of in-stent restenosis

NATICK, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Express2(TM) Atom(TM) Paclitaxel-Eluting Coronary Stent System. The TAXUS Express Atom Stent is a highly deliverable drug-eluting stent (DES) specifically designed for treating small coronary vessels. It is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter. No other DES for sale in the U.S. market is approved for use in vessels smaller than 2.50 mm in diameter. The Company plans to launch the product immediately.

The Company today also announced FDA approval of its TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System for the treatment of in-stent restenosis in bare-metal stents. This is the first such approval granted by the FDA, making the TAXUS Express2 Stent System the only drug-eluting stent approved in the United States for the treatment of in-stent restenosis in bare-metal stents.

"The TAXUS Express Atom Stent will provide better options for U.S. patients with coronary artery disease in small vessels," said Gregg Stone, M.D., Chairman of the Cardiovascular Research Foundation and Professor of Medicine at Columbia University Medical Center, and Principal Investigator of the TAXUS IV and V clinical trials. "This is a welcome addition to the range of available drug-eluting stents, since patients with small vessels who are currently treated with bare-metal stents experience high rates of restenosis. In the TAXUS V clinical trial, the TAXUS
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific to Participate in UBS Global Life Sciences Conference
2. Boston Scientific Announces Court Decision
3. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
4. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
5. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
6. TechCFO Adds Gary Strickland as Partner in Boston Office
7. Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
8. Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
9. Boston Scientific Welcomes Revised Outlook From Fitch Ratings
10. Boston Scientific to Participate in Goldman Sachs Conference
11. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY ) ... Chief Executive Officer, will present at the Rodman & Renshaw ... New York on Tuesday, Sept. 9, 2014 at ... webcast of the presentation will be accessible by visiting the ... section. About Oncothyreon Oncothyreon ...
(Date:9/2/2014)... 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the ... orders consist of three large odour control systems for waste ... "These orders are consistent with the market resurgence in ... , President and CEO. "After a difficult period of restraint ... beginning to see sales growth. Our lower cost structure, technology ...
(Date:9/2/2014)... , Sept. 2, 2014  Spherix Incorporated (SPEX) -- an ... monetization of intellectual property, today announced that the United ... to the Company in the month of August that ... The issued patents are: ... U.S.RE45,081 issued August 19, 2014; and , U.S.RE45,095 ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The inventors ... cure for chronic tinnitus are seeking support for development ... the Indiegogo platform ( http://igg.me/at/tinaway ), was launched on ... a therapeutic ‘mHealth’ app and is based on ten ... a team of biomedical and software engineers, Dr. Ian ...
Breaking Biology Technology:United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 3tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 4tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 5
... it; you brought Bill Gates to his tender knees. Oh, yes, ... you worm writer, you!" It echoed among the buildings, all but ... beneath the whimpers you could almost hear Billy saying it: "I ... fix my software."* , ,Wow, if only the U.S. ...
... electricity-usage growth rate, we wont have enough power in 15 ... company. With a 2.5 percent growth rate, if we dont ... keep the lights on in 15 years, especially in this ... ,Paul Wilson, Ph.D, assistant professor of engineering physics at the ...
... consultants and executives are reporting that there are early ... half of 2003, which provides the necessary first steps ... ,Steve Haroldson, chief technology officer for CUNA Mutual Group ... talk regularly with technology vendors, and over the last ...
Cached Biology Technology:Open Letter: Blasted Worm 2Open Letter: Blasted Worm 3Software Company Tackles Energy Shortage Issues 2IT Spending to Increase in Second Half of 2003 2IT Spending to Increase in Second Half of 2003 3IT Spending to Increase in Second Half of 2003 4IT Spending to Increase in Second Half of 2003 5
(Date:9/2/2014)... Bavaria, the Tithonian Konservat-Lagersttte of lithographic limestone is ... of emblematic fossils from that area (for example, ... found fossil insects in the French equivalent of ... species representing the oldest known water treader. , ... Bavarian outcrops, fewer fossils have been obtained from ...
(Date:9/1/2014)... making us fat? An increasing amount of research shows ... and a more sedentary lifestyle. Now, a new Cornell ... alike. Some TV programs might lead people to eat ... if you,re watching an action movie while snacking your ... Ph.D. lead author on the new article just published ...
(Date:9/1/2014)... that corals whose calcium-carbonate skeletons form the ... that rely entirely on ocean currents to deliver ... now scientists at MIT and the Weizmann Institute ... they are far from passive, engineering their environment ... enhance their ability to exchange nutrients and dissolved ...
Breaking Biology News(10 mins):Exceptionally well preserved insect fossils from the Rhône Valley 2Can action movies make you fat? 2Nature's tiny engineers 2Nature's tiny engineers 3
... of olive ridley sea turtles off the coast of ... be inadequate to safeguard turtles from fishing nets, according ... Wildlife Conservation Society, the University of Exeter, and others. ... an international marine park that spans the waters of ...
... Germs survive for several days in wind ... a pilot study published in the International Journal ... Stuart Levy, MD, of Tufts University School of Medicine, ... a need for additional research to determine the conditions ...
... DALLAS May 12, 2011 UT Southwestern Medical ... development and eventually might lead to a treatment to keep ... that the Ras interacting protein 1 (Rasip1) is so specific ... new blood vessels simply cannot form, said Dr. Ondine Cleaver, ...
Cached Biology News:Africa's sea turtles need passports for protection 2Africa's sea turtles need passports for protection 3Sharing musical instruments means sharing germs 2UT Southwestern researchers find protein that might be key to cutting cancer cells' blood supply 2